We're introducing collaboration opportunities in various fields for the growth and innovation of CRISPR gene editing technology. ToolGen, as the pioneer of CRISPR-Cas9 technology, and owner of foundational CRISPR-Cas9 patents, operates an special team comprising legal experts, patent specialists, and licensing professionals, aimed to strategic partnering and licensing. Our goal is to foster innovation and contribute to global industries through the responsible advancement of CRISPR technology.
Feel free to reach out if you're interested in exploring licensing possibilities or have inquiries about our IP practices. Join us as we shape the future of CRISPR genome editing together.